阅读说明：本技术 用于治疗癌症的usl-311 (USL-311 for treating cancer ) 是由 彼得·理查森 于 2018-03-09 设计创作，主要内容包括：本发明涉及CXCR4拮抗剂6-{4-[1-(丙-2-基)哌啶-4-基]-1,4-二氮杂环庚烷-1-基}-N-(吡啶-4-基)吡啶-2-甲酰胺或其可药用盐在治疗乳腺癌、膀胱癌、结肠癌、直肠癌或肝癌中的用途。(The present invention relates to the purposes of CXCR4 antagonist 6- { 4- [1- (propyl- 2- yl) piperidin-4-yl]-Isosorbide-5-Nitrae-Diazesuberane -1- base }-N- (pyridin-4-yl) pyridine-2-carboxamide or its officinal salt in treatment breast cancer, bladder cancer, colon and rectum carcinoma or liver cancer.)